Human cytomegalovirus gB polypeptide
US-12447207-B2 · Oct 21, 2025 · US
Cytomegalovirus
Cytomegalovirus · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K14/045 |
| Official title | Cytomegalovirus |
| Display label | Cytomegalovirus |
| Total patents | 61 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is rapidly declining.
| Year | Patents |
|---|---|
| 2015 | 1 |
| 2016 | 9 |
| 2017 | 5 |
| 2018 | 2 |
| 2019 | 8 |
| 2020 | 5 |
| 2021 | 5 |
| 2022 | 12 |
| 2023 | 5 |
| 2024 | 7 |
| 2025 | 2 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Clinical methods for use of a PD-L1-binding molecule comprising a Shiga toxin effector
US-12180284-B2 · Dec 31, 2024 · US
Modified cytomegalovirus proteins and stabilized complexes
US-2024383949-A1 · Nov 21, 2024 · US
Human cytomegalovirus gb polypeptide
US-2024100153-A1 · Mar 28, 2024 · US
Modified cytomegalovirus proteins and stabilized complexes
US-11932669-B2 · Mar 19, 2024 · US
Immunogenic peptide
US-2024058437-A1 · Feb 22, 2024 · US
Cmv vaccine and method of making and using the same
US-2024041994-A1 · Feb 8, 2024 · US
Human cytomegalovirus GB polypeptide
US-11857622-B2 · Jan 2, 2024 · US
Methods and compositions for eliminating engineered immune cells
US-2023405047-A1 · Dec 21, 2023 · US
Expression system for expressing herpesvirus glycoprotein complexes
US-11844833-B2 · Dec 19, 2023 · US
Ii vaccine adjuvant
US-11813327-B2 · Nov 14, 2023 · US
Human cytomegalovirus comprising exogenous antigens
US-11692012-B2 · Jul 4, 2023 · US
Expression system for expressing herpesvirus glycoprotein complexes
US-2023140549-A1 · May 4, 2023 · US
Human cytomegalovirus vaccine
US-2022401551-A1 · Dec 22, 2022 · US
Precision activation of HIV-specific CTLS to eliminate reactivated latent T cells
US-11407806-B2 · Aug 9, 2022 · US
Human cytomegalovirus vaccine
US-11406703-B2 · Aug 9, 2022 · US
Expression system for expressing herpesvirus glycoprotein complexes
US-11389529-B2 · Jul 19, 2022 · US
Clinical methods for use of a pd-l1-binding molecule comprising a shiga toxin effector
US-2022195050-A1 · Jun 23, 2022 · US
Complexes of cytomegalovirus proteins
US-2022106364-A1 · Apr 7, 2022 · US
Li vaccine adjuvant
US-2022105178-A1 · Apr 7, 2022 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K14/045?
- CPC C07K14/045 is the Cooperative Patent Classification code for “Cytomegalovirus.”
- How many patents are filed under CPC C07K14/045 (Cytomegalovirus)?
- Our database includes 61 publications tagged with this CPC code.
- Is patent activity under CPC C07K14/045 growing?
- Publication counts under this code: 7 in 2024 vs 2 in 2025 (latest complete years).